Clinical Study

Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy

Table 2

Correlations between MV subpopulations and parameters associated with components of MetSy and T2D at baseline.

BMIWaistTotal fat massLean body massFat %HbA1cTotal cholesterolLDLHDLTGALTGGTHGP: baseHGP: clampC-peptide: baseInsulin: fastingInsulin clearance

Lactadherin+0,180,080,090,200,000,300,150,06−0,160,27−0,210,120,250,30−0,04
CD41+0,060,090,080,210,000,140,32−0,180,17−0,070,160,270,140,24−0,19
CD41+/CD36+−0,010,050,040,18−0,030,03−0,110,130,000,160,250,080,18−0,16
CD62E+0,120,040,080,31-0,060,080,300,14−0,060,16−0,180,130,140,250,31−0,03
CD62E+/CD36+0,03−0,04−0,080,27−0,220,180,300,14−0,010,010,190,050,190,130,100,17−0,04
CD14+0,180,100,180,180,140,100,200,09−0,230,190,26−0,190,140,210,30−0,19
CD14+/CD36+0,220,28−0,130,220,09−0,21−0,260,030,17−0,11

Spearman’s ranked correlation coefficients (rS). ; ; < 0.001. Difference in disposal rate at baseline and during clamp.